Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

State of Alaska Department of Revenue lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 1.6% in the fourth quarter, HoldingsChannel reports. The fund owned 21,325 ...

The Wagoner County Sheriff's Office (WCSO) released body cam video of deputies responding to a diabetic driver who went off the roadway and crashed into a tree ...

Boehringer Ingelheim, GSK, Novartis, Teva, and Covis Pharma have been taken to task for asthma and COPD inhalers, while Amphastar Pharma has been warned over its Baqsimi glucagon nasal spray ...

This raises your blood sugar level. Baqsimi is a nasal spray. It’s given as one spray into one nostril during an episode of severe hypoglycemia. With severe hypoglycemia, your blood sugar level ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...